Introduction
The Jun activation-domain binding protein 1 (Jab1) is initially identified as a coactivator of activator protein (AP-1) transcription factor and found a component of the COP9 signalosome (CSN) complex, contained modulating signal transduction, gene transcription, and protein stability. 1, 2 Jab1 interacted with p27 kip1 and translocate it' s from nuclear to cytoplasm which resulted in acceleration of p27 kip1 degradation through the ubiquitin-dependent/proteasome pathway and promotes cell-cycle progression. 3 p27 kip1 is an inhibitor of cyclin-dependent kinases (CDKs), performing potential tumor suppressor gene in diversity of human' s cancer.
CDK is a family of protein kinases, the activity of the serine/ threonine kinases known as cdk that are under the strict control of positive and negative regulators. Until now studies have found that p27 kip1 promotes apoptosis, growth inhibition and cell cycle arrest. 4, 5 Reduction of p27 kip1 protein means high resistance and poor prognosis to anticancer drug.
Down regulation of p27 kip1 protein is often discovered by human cancers including breast and ovarian cancer and is normally correlated with poor clinical outcome. As a result, the concentration of the p27 kip1 protein can be expressed as an important marker in the development of human cancer.
Accordingly, this study examines a correlation of p27 kip1 and Jab1, will reveal the relevant disease in women.
Jab1, p27 Kip1 Structure and Function
Jab1 has been involved to the tumorigenic process, therefore, jab1 have the potential to be an effective beneficial
The Jun activation-domain binding protein 1 (Jab1) recognize a potential coactivator of activator protein 1 (AP-1) such as c-fos, c-jun transcription factor and the fifth subunit of the COP9 signalosome complex. Also, Jab1 activate the c-jun gene resulted cell proliferation. Not only a powerful tumor suppressor but also regulator of apoptosis negative cdk inhibitor p27 kip1 are involved in the cell cycle. This is Jab1 and p27 kip1 interact with each other, Jab1 accelerate p27 kip1 from nuclear to cytoplasm through ubiquitin/ proteasome pathway. However, information about the relationship between Jab1 and p27 kip1 is not known much. Taken together, the results of this study identify function and structure of Jab1 and p27 kip1 were described in a recent article on the basis of relevant.
Besides Jab1 and p27 kip1 will organize the relationship between the disease and women. target that affect the interaction of many tumor stage. Size of Jab1 is an -40 kDa soluble protein, also Jab1 is located on chromosome 8. Jab1 interacted with p27 kip1 and improved its cytoplasmic translocation which resulted in acceleration of p27 kip1 degradation through the ubiquitin and proteasome pathway. It is well known that p27 kip1 protein levels are mainly regulated through degradation by ubiquitindependent proteolysis. Control of p27 kip1 and Jab1 is important process in cancer progression, which is controlled by both the positive and negative regulators. p27 kip1 is a kind of cdk inhibitors, suppresses the G1-to-S cell cycle progression, functions as a main negative regulator of apoptosis and is, thus, considered a tumor suppressor. 6 The main function of this p27 kip1 is to inhibit the CDK2-cyclin E complex by controlling at the G1 to S transition in normal cells.
Jab1, p27 kip1 and Breast Cancer
Jab1 is an important protein in breast cancer progression comes from the recent study that it is a downstream target for HER2-2/neu. 
P27 kip1 and Endometriosis
Endometriosis is the endometrial tissue in the uterus that should be present in the abdominal cavity outside the uterus, 9 a common disease that occurs in approximately 10 to 
Jab1, p27 and Ovarian Cancer
Ovarian cancer is malignant tumor, the most widely occurring between 50 to 70 years old woman. 16, 17 The second most common cause of gynecologic cancer in succession cervical cancer has been identified as a family history, a lot of ovulation number. No proven method for ovarian cancer is often rapidly progressive and fatal disease early symptoms rarely. 5 As a negative regulator of the cell cycle, p27 kip1 is tumor suppressor, 6 which inhibits cyclin-CDK in a dosage dependent manner to control cell cycle progression. 7, 8 Recently, decreased expression of p27 kip1 has been frequently detected in human cancers, 5,10~15 including ovarian carcinoma. Recently, the expression of Jab1 and p27 kip1 in a malignant epithelial ovarian cancer, was found to be correlated with the reverse p27 kip1 expression levels as a result Jab1 negative regulator. 18 That is a negative regulator of p27 kip1 Jab1 has been associated with the development of the ovarian tumor, progression and prognosis. 
